These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37887994)

  • 21. The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2.
    Wu CP; Hsieh YJ; Tseng HY; Huang YH; Li YQ; Hung TH; Wang SP; Wu YS
    Biomed Pharmacother; 2022 Oct; 154():113663. PubMed ID: 36081287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).
    Elkind NB; Szentpétery Z; Apáti A; Ozvegy-Laczka C; Várady G; Ujhelly O; Szabó K; Homolya L; Váradi A; Buday L; Kéri G; Német K; Sarkadi B
    Cancer Res; 2005 Mar; 65(5):1770-7. PubMed ID: 15753373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
    Ozvegy C; Váradi A; Sarkadi B
    J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.
    Xie Y; Xu K; Linn DE; Yang X; Guo Z; Shimelis H; Nakanishi T; Ross DD; Chen H; Fazli L; Gleave ME; Qiu Y
    J Biol Chem; 2008 Feb; 283(6):3349-3356. PubMed ID: 18056989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.
    Henriksen U; Fog JU; Litman T; Gether U
    J Biol Chem; 2005 Nov; 280(44):36926-34. PubMed ID: 16107343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
    Henriksen U; Gether U; Litman T
    J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCG2 -- a transporter for all seasons.
    Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A
    FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple common and rare variants of
    Higashino T; Takada T; Nakaoka H; Toyoda Y; Stiburkova B; Miyata H; Ikebuchi Y; Nakashima H; Shimizu S; Kawaguchi M; Sakiyama M; Nakayama A; Akashi A; Tanahashi Y; Kawamura Y; Nakamura T; Wakai K; Okada R; Yamamoto K; Hosomichi K; Hosoya T; Ichida K; Ooyama H; Suzuki H; Inoue I; Merriman TR; Shinomiya N; Matsuo H
    RMD Open; 2017; 3(2):e000464. PubMed ID: 29225919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional non-synonymous variants of ABCG2 and gout risk.
    Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
    Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.
    Zhang W; Yang Y; Dong Z; Shi Z; Zhang JT
    J Biol Chem; 2019 Dec; 294(52):20222-20232. PubMed ID: 31719146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ABCG2/BCRP in biology and medicine.
    Krishnamurthy P; Schuetz JD
    Annu Rev Pharmacol Toxicol; 2006; 46():381-410. PubMed ID: 16402910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.
    Litman T; Jensen U; Hansen A; Covitz KM; Zhan Z; Fetsch P; Abati A; Hansen PR; Horn T; Skovsgaard T; Bates SE
    Biochim Biophys Acta; 2002 Sep; 1565(1):6-16. PubMed ID: 12225847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
    Ji N; Yuan J; Liu J; Tian S
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter.
    Ozvegy-Laczka C; Laczkó R; Hegedus C; Litman T; Várady G; Goda K; Hegedus T; Dokholyan NV; Sorrentino BP; Váradi A; Sarkadi B
    J Biol Chem; 2008 Sep; 283(38):26059-70. PubMed ID: 18644784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.
    Cleophas MC; Joosten LA; Stamp LK; Dalbeth N; Woodward OM; Merriman TR
    Pharmgenomics Pers Med; 2017; 10():129-142. PubMed ID: 28461764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
    Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
    PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
    Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
    Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
    Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
    Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.